{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:43:25Z","timestamp":1792464205637,"version":"4.5.0"},"reference-count":63,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oradea"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Alzheimer\u2019s disease (AD) is a progressive neurodegenerative condition that significantly affects cognitive, emotional, and functional abilities in older adults. This study aimed to explore how demographic, clinical, and psychological factors influence the progression of cognitive decline in patients diagnosed with AD. Materials and Methods: A total of 101 patients were evaluated retrospectively and followed longitudinally at three different time points, using standardized instruments, including the MMSE, Reisberg\u2019s GDS, clock-drawing test, MADRS, and Hamilton depression scale. Statistical methods included non-parametric tests, mixed-effect modeling, and Bayesian analysis. Results: Most patients were older women from rural areas, predominantly in moderate-to-severe stages of AD. Age showed a significant association with cognitive decline (p &lt; 0.05), and depression\u2014particularly in moderate and severe forms\u2014was strongly linked to lower MMSE scores (p &lt; 0.001). Over 70% of the participants had some degree of depression. The clock-drawing test highlighted visuospatial impairments, consistent with everyday functional loss. Although donepezil and memantine combinations appeared to be more frequently prescribed, no treatment showed a statistically significant advantage, and confidence interval overlaps suggest caution in interpreting differences between therapies. Longitudinal models confirmed a progressive and accelerated decline, with inter-individual variability becoming more pronounced in later stages. Although comorbidities, such as hypertension and diabetes, were frequent, they did not show a statistically significant effect on MMSE scores in this cohort. Conclusions: Age and depression appear to play central roles in the pace of cognitive deterioration in AD. Given the limited efficacy of most current therapies, these findings highlight the need for earlier intervention and a more personalized, integrated approach\u2014combining cognitive care, psychiatric support, and comorbidity management\u2014to better meet the needs of patients with AD.<\/jats:p>","DOI":"10.3390\/medicina61050877","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T11:31:49Z","timestamp":1747135909000},"page":"877","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictors of Cognitive Decline in Alzheimer\u2019s Disease: A Longitudinal Bayesian Analysis"],"prefix":"10.3390","volume":"61","author":[{"given":"Denisa Claudia","family":"Negru","sequence":"first","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0296-6592","authenticated-orcid":false,"given":"Delia Mirela","family":"Tit","sequence":"additional","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9898-0753","authenticated-orcid":false,"given":"Paul Andrei","family":"Negru","sequence":"additional","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Bungau","sequence":"additional","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3182-1683","authenticated-orcid":false,"given":"Ruxandra Cristina","family":"Marin","sequence":"additional","affiliation":[{"name":"Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","article-title":"The Alzheimer\u2019s Disease Clinical Spectrum: Diagnosis and Management","volume":"103","author":"Atri","year":"2019","journal-title":"Med. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2015). 2015 Alzheimer\u2019s disease facts and figures. Alzheimers Dement., 11, 332\u2013384.","DOI":"10.1016\/j.jalz.2015.02.003"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1097\/MJT.0000000000001120","article-title":"A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer Dementia","volume":"27","author":"Paunescu","year":"2020","journal-title":"Am. J. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ane.13551","article-title":"Microglia and immunotherapy in Alzheimer\u2019s disease","volume":"145","author":"Li","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/alzrt48","article-title":"Review of Alzheimer\u2019s disease scales: Is there a need for a new multi-domain scale for therapy evaluation in medical practice?","volume":"2","author":"Robert","year":"2010","journal-title":"Alzheimers Res. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jalz.2009.05.667","article-title":"Scales as outcome measures for Alzheimer\u2019s disease","volume":"5","author":"Black","year":"2009","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chatterjee, S., and Mudher, A. (2018). Alzheimer\u2019s Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00383"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41533","DOI":"10.1007\/s11356-021-14675-y","article-title":"Uncurtaining the pivotal role of ABC transporters in diabetes mellitus","volume":"28","author":"Behl","year":"2021","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"S\u00e1iz-V\u00e1zquez, O., Gracia-Garc\u00eda, P., Ubillos-Landa, S., Puente-Mart\u00ednez, A., Casado-Yusta, S., Olaya, B., and Santab\u00e1rbara, J. (2021). Depression as a Risk Factor for Alzheimer\u2019s Disease: A Systematic Review of Longitudinal Meta-Analyses. J. Clin. Med., 10.","DOI":"10.3390\/jcm10091809"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/acschemneuro.9b00607","article-title":"Association of Intestinal Disorders with Parkinson\u2019s Disease and Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"11","author":"Fu","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Valentine, D., Teerlink, C.C., Farnham, J.M., Rowe, K., Kaddas, H., Tschanz, J., Kauwe, J.S.K., and Cannon-Albright, L.A. (2022). Comorbidity and Cancer Disease Rates among Those at High-Risk for Alzheimer\u2019s Disease: A Population Database Analysis. Int. J. Environ. Res. Public. Health, 19.","DOI":"10.3390\/ijerph192416419"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Haaksma, M.L., Vilela, L.R., Marengoni, A., Calder\u00f3n-Larra\u00f1aga, A., Leoutsakos, J.-M.S., Olde Rikkert, M.G.M., and Melis, R.J.F. (2017). Comorbidity and progression of late onset Alzheimer\u2019s disease: A systematic review. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177044"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2337\/dc18-1399","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer\u2019s Disease","volume":"42","author":"McIntosh","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00125-015-3515-x","article-title":"Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998-2011: A retrospective national record linkage cohort study","volume":"58","author":"Smolina","year":"2015","journal-title":"Diabetologia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.ede.0000152116.32580.24","article-title":"Depression and the risk of Alzheimer disease","volume":"16","author":"Andersen","year":"2005","journal-title":"Epidemiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1017\/S0033291709991577","article-title":"Affective symptoms as predictors of Alzheimer\u2019s disease in subjects with mild cognitive impairment: A 10-year follow-up study","volume":"40","author":"Ramakers","year":"2010","journal-title":"Psychol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-3223(93)90383-O","article-title":"Geriatric depression: Age of onset and dementia","volume":"34","author":"Alexopoulos","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002093-199903000-00007","article-title":"History of depression and other psychiatric illness as risk factors for Alzheimer disease in a twin sample","volume":"13","author":"Wetherell","year":"1999","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1590\/1980-5764-dn-2021-0097","article-title":"45 Years of the mini-mental state examination (MMSE): A perspective from ibero-america","volume":"16","author":"Gallegos","year":"2022","journal-title":"Dement. Neuropsychol."},{"key":"ref_21","first-page":"343","article-title":"Driving: What is the relevance and usability of the Reisberg scale in 2023?","volume":"21","author":"Lazeras","year":"2023","journal-title":"Geriatr. Psychol. Neuropsychiatr. Vieil."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Navickaite, E., Saltvedt, I., Lydersen, S., Munthe-Kaas, R., Ihle-Hansen, H., Grambaite, R., and Aam, S. (2024). Diagnostic accuracy of the Clock Drawing Test in screening for early post-stroke neurocognitive disorder: The Nor-COAST study. BMC Neurol., 24.","DOI":"10.1186\/s12883-023-03523-w"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/mpr.1388","article-title":"The structure of the Montgomery\u2013\u00c5sberg depression rating scale over the course of treatment for depression","volume":"22","author":"Quilty","year":"2013","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000506879","article-title":"The Hamilton Rating Scales for Depression: A Critical Review of Clinimetric Properties of Different Versions","volume":"89","author":"Carrozzino","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"ref_25","unstructured":"(2025, April 05). R: The R Project for Statistical Computing. Available online: https:\/\/www.r-project.org\/."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Miculas, D.C., Negru, P.A., Bungau, S.G., Behl, T., Hassan, S.S.u., and Tit, D.M. (2022). Pharmacotherapy Evolution in Alzheimer\u2019s Disease: Current Framework and Relevant Directions. Cells, 12.","DOI":"10.3390\/cells12010131"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3233\/JAD-180141","article-title":"Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer\u2019s Disease","volume":"64","author":"Beam","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_28","first-page":"e58416","article-title":"A Review of Recent Advances in the Management of Alzheimer\u2019s Disease","volume":"16","author":"Thangwaritorn","year":"2024","journal-title":"Cureus"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/acn3.166","article-title":"A practical algorithm for managing Alzheimer\u2019s disease: What, when, and why?","volume":"2","author":"Cummings","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10.3.1","DOI":"10.1002\/0471142301.ns1003s49","article-title":"Unit 10.3: Assessment of Cognitive Impairments in the Diagnosis of Alzheimer\u2019s Disease","volume":"49","author":"Baldwin","year":"2009","journal-title":"Curr. Protoc. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S1980-57642011DN05030003","article-title":"Cognitive, functional and behavioral assessment: Alzheimer\u2019s disease","volume":"5","author":"Chaves","year":"2011","journal-title":"Dement. Neuropsychol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jclinepi.2020.04.022","article-title":"Hamilton Scale and MADRS Are Interchangeable in Meta-Analyses but Can Disagree at Trial Level","volume":"124","author":"Guizzaro","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"ref_33","unstructured":"(2025, April 05). Cognitive Screening and Assessment | Alzheimer\u2019s Association. Available online: https:\/\/www.alz.org\/professionals\/health-systems-medical-professionals\/cognitive-assessment."},{"key":"ref_34","first-page":"e12217","article-title":"Current advances in digital cognitive assessment for preclinical Alzheimer\u2019s disease","volume":"13","author":"Hassenstab","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/070674371105601003","article-title":"Pharmacological treatment of Alzheimer disease","volume":"56","author":"Massoud","year":"2011","journal-title":"Can. J. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s13670-013-0056-3","article-title":"Treatment of Alzheimer\u2019s Disease: Current Management and Experimental Therapeutics","volume":"2","author":"Honig","year":"2013","journal-title":"Curr. Transl. Geriatr. Exp. Gerontol. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"(2024). 2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement., 20, 3708\u20133821.","DOI":"10.1002\/alz.13809"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/WAD.0b013e318211c83c","article-title":"The Relationship between Education and Dementia An Updated Systematic Review","volume":"25","author":"Sharp","year":"2011","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Silva, M.V.F., and Loures, C. (2019). de M.G.; Alves, L.C.V.; de Souza, L.C.; Borges, K.B.G.; Carvalho, M. d. G. Alzheimer\u2019s disease: Risk factors and potentially protective measures. J. Biomed. Sci., 26.","DOI":"10.1186\/s12929-019-0524-y"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CLEP.S37929","article-title":"Clinical epidemiology of Alzheimer\u2019s disease: Assessing sex and gender differences","volume":"6","author":"Mielke","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/psyg.12338","article-title":"Cardiovascular and metabolic comorbidities in patients with Alzheimer\u2019s disease and vascular dementia compared to a psychiatric control cohort","volume":"18","author":"Vogelgsang","year":"2018","journal-title":"Psychogeriatrics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e025724","DOI":"10.1161\/JAHA.122.025724","article-title":"Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach","volume":"12","author":"Ruthirakuhan","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1590\/S1980-57642009DN20400011","article-title":"Comparison of the Mini Mental State Examination and depressive symptoms between high cardiovascular risk and healthy community elderly groups","volume":"2","author":"Varela","year":"2008","journal-title":"Dement. Neuropsychol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Li, K., Qu, H., Ma, M., Xia, C., Cai, M., Han, F., Zhang, Q., Gu, X., and Ma, Q. (2022). Correlation Between Brain Structure Atrophy and Plasma Amyloid-\u03b2 and Phosphorylated Tau in Patients With Alzheimer\u2019s Disease and Amnestic Mild Cognitive Impairment Explored by Surface-Based Morphometry. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.816043"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.biopsych.2020.12.015","article-title":"High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank","volume":"89","author":"Sproviero","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"ref_46","unstructured":"(2025, April 05). Longitudinal Hippocampal Atrophy Is Associated with Cognitive Decline Independently of Amyloid and Tau in Neocortex-Hanseeuw-2022-Alzheimer\u2019s & Dementia-Wiley Online Library. Available online: https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/full\/10.1002\/alz.069271."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.clineuro.2006.02.003","article-title":"Pr\u00e9AL study Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer\u2019s disease: A one-year follow-up study","volume":"108","author":"Robert","year":"2006","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1176\/appi.ajp.160.5.857","article-title":"A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer\u2019s disease","volume":"160","author":"Zubenko","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Behl, T., Makkar, R., Sehgal, A., Singh, S., Sharma, N., Zengin, G., Bungau, S., Andronie-Cioara, F.L., Munteanu, M.A., and Brisc, M.C. (2021). Current Trends in Neurodegeneration: Cross Talks between Oxidative Stress, Cell Death, and Inflammation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147432"},{"key":"ref_50","first-page":"77","article-title":"Alzheimer\u2019s disease\u2013estrogens and selective estrogen receptor modulators, friends or foes?","volume":"13","author":"Coman","year":"2017","journal-title":"Acta Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jagp.2020.12.031","article-title":"Depression and Increased Risk of Alzheimer\u2019s Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors","volume":"29","author":"Kim","year":"2021","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Conti Filho, C.E., Loss, L.B., Marcolongo-Pereira, C., Rossoni Junior, J.V., Barcelos, R.M., Chiarelli-Neto, O., da Silva, B.S., Passamani Ambrosio, R., Castro, F.C.d.A.Q., and Teixeira, S.F. (2023). Advances in Alzheimer\u2019s disease\u2019s pharmacological treatment. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1101452"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3233\/JAD-215423","article-title":"The Efficacy and Safety of Alzheimer\u2019s Disease Therapies: An Updated Umbrella Review","volume":"85","author":"Fan","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11357-023-01030-x","article-title":"Investigating the association between a history of depression and biomarkers of Alzheimer\u2019s disease, cerebrovascular disease, and neurodegeneration in patients with dementia","volume":"46","author":"Salwierz","year":"2023","journal-title":"GeroScience"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/JGP.0b013e31818b4111","article-title":"The Montgomery-Asberg Depression Rating Scale and the Cornell Scale for Depression in Dementia: A validation study with patients exhibiting early-onset dementia","volume":"17","author":"Leontjevas","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e70058","DOI":"10.1002\/hsr2.70058","article-title":"Depression detection in dementia: A diagnostic accuracy systematic review and meta analysis update","volume":"7","author":"Atchison","year":"2024","journal-title":"Health Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1177\/0962280217748675","article-title":"Bayesian hidden Markov models for delineating the pathology of Alzheimer\u2019s disease","volume":"28","author":"Kang","year":"2019","journal-title":"Stat. Methods Med. Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Alexiou, A., Mantzavinos, V.D., Greig, N.H., and Kamal, M.A. (2017). A Bayesian Model for the Prediction and Early Diagnosis of Alzheimer\u2019s Disease. Front. Aging Neurosci., 9.","DOI":"10.3389\/fnagi.2017.00077"},{"key":"ref_59","first-page":"e71346","article-title":"Revisiting Depression Rating Scales: Analysis of a Randomized Trial","volume":"16","author":"Santi","year":"2024","journal-title":"Cureus"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_61","unstructured":"(2025, April 05). Anti-Amyloid Therapies Do Not Slow Alzheimer\u2019s Disease Progression-PMC, Available online: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10768645\/."},{"key":"ref_62","first-page":"e12584","article-title":"Risk of depression in persons with Alzheimer\u2019s disease: A national cohort study","volume":"16","author":"Crump","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3233\/ADR-230027","article-title":"Cognitive Trajectories in Preclinical and Prodromal Alzheimer\u2019s Disease Related to Amyloid Status and Brain Atrophy: A Bayesian Approach","volume":"7","author":"Teipel","year":"2023","journal-title":"J. Alzheimer\u2019s Dis. Rep."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/877\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:30:54Z","timestamp":1760031054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/5\/877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["medicina61050877"],"URL":"https:\/\/doi.org\/10.3390\/medicina61050877","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]}}}